WhatsApp
Biovedic Life sciences offers a range of analytical solutions supported by state of the art facilities, advanced analytical instruments and efficient analytical team. The analytical team works closely with our chemists and takes charge for method development, preparative purification and characterization, allowing the chemists to target the trouble-shooting time and efficiency, on delivery of chemistry. Our analytical scientists use appropriate techniques and instrumentation to quantify and qualify new chemical entities, drug substances, drug products and their related analyses.
- Method development & validation
- Impurity profiling
- Stability Studies
Capabilities
Our analytical solutions are phase-appropriate and executed in parallel. Our approach is iterative, focusing on continuous improvement so that the developed and validated methods support the progress of customer drug candidates.
Our analytical and regulatory teams provide additional support, post submission for regulatory approval.
Our robust quality assurance systems ensure close monitoring, review and approval of stability studies before release of reports.
We have a proven track record of successful submissions of protocols and reports to global regulators.
| IMPURITY/ STANDARD NAME | CAS No. |
|---|---|
| Telmisartan | |
| 1-methyl-2-(4-methyl-2-propyl-1H-inden-6-yl)-1H-benzo[d] imidazole hydrate/BIM.H2O | 1282554-35-1 |
| 4'-(bromomethyl)-[1,1'-biphenyl]-2-carbonitrile / Br-OTBN | 114772-54-2 |
| Telmisartan-Isomer /4'-((1,4'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid/ IMP-B | 1026353-20-7 |
| Telmisartan-Amide /2-(4-{[4-Methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl] methyl}phenyl)benzamide | 915124-86-6 |
| Telmisartan Dimer Impurity /4',4'''-((7'-methyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazole]-1,3'-diyl)bis(methylene))bis(([1,1'-biphenyl]-2-carboxylic acid)) | 884330-14-7 |
| 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carbonitrile | 144702-27-2 |
| Telmisartan (API)EP, USP & IP/4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid | 144701-48-4 |
| Di methyl fumarate | |
| Fumaric Acid Monomethyl Ester | 2756-87-8 |
| Dimethyl Fumarate - API Standard | 624-49-7 |
| Valsartan | |
| L-Valine methyl ester hydrochloride | 6306-52-1 |
| methyl (2S)-2-(((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)amino)-3-methylpentanoate hydrochloride | NA |
| methyl ((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-L-valinate hydrochloride | 482577-59-3 |
| L-Isoleucine methyl ester hydrochloride | 18598-74-8 |
| Amlodipine | |
| 3-Ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate /Imp-A (EP) | 88150-62-3 |
| Ethyl 4-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)-3-oxobutanoate | 88150-75-8 |
| methyl 4-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)-3-oxobutanoate | 111429-90-4 |
| 2-(2-Hydroxyethyl)isoindoline 1,3-dione | 727384 |
| dimethyl 4-(2-chlorophenyl)-2-((2-(1,3-dioxoisoindolin-2-yl)ethoxy)methyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate/Imp-F-precursor | 140171-50-2 |
| diethyl 4-(2-chlorophenyl)-2-((2-(1,3-dioxoisoindolin-2-yl)ethoxy)methyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate/Imp-E-precursor | 140171-49-9 |
| diethyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate/Imp-E(EP) | 140171-65-9 |
| dimethyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate/Imp-F(EP) | 140171-66-0 |
| 3-Ethyl 5-Methyl (4RS)-4-(2-Chlorophenyl)-6-methyl-2-[[2-[[2-(methylcarbamoyl) benzoyl]amino]ethoxy]methyl]-1,4-dihydropyridine-3,5-dicarboxylate/Imp-B (EP) | 721958-72-1 |
| 2-Carboxybenzoyl Amlodipine Imp-H (EP)/2-((2-((4-(2-chlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridin-2-yl)methoxy)ethyl)carbamoyl) benzoic acid | 318465-73-5 |
| (R)-Amlodipine /3-ethyl 5-methyl (R)-2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate | 103129-81-3 |
| (S)-Amlodipine /3-ethyl 5-methyl (S)-2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate | 103129-82-4 |
| 3-(2-(1,3-dioxoisoindolin-2-yl)ethyl) 5-methyl 4-(2-chlorophenyl)-2-((2-(1,3-dioxoisoindolin-2-yl)ethoxy)methyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate/Diphthaloyl Amlodipine imp. | NA |
| ethyl -2-(2-chlorobenzylidene)-4-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)-3-oxobutanoate | 400024-08-0 |
| Amlodipine Base (Racemic)/3-ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate | 88150-42-9 |
| Dimethyl 4-(2-Chlorophenyl)-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxylate/ Imp-G (EP) | 43067-01-2 |
| Amlodipine Besylate (EP,USP &IP) | 111470-99-6 |
| Amlodipine Mesylate | 246852-12-0 |
| (S)-Amlodipine Besylate (IP) | 150566-71-5 |
| Amlodipine Maleate | 88150-47-4 |
| Linagliptin/Alogliptin /Trelagliptin | |
| Dimethyl L-glutamate hydrochloride | 23150-65-4 |
| Dimethyl D-glutamate hydrochloride | 27025-25-8 |
| Di methyl N-Boc-L-Glutamate/dimethyl (tert-butoxycarbonyl)-L-glutamate | 59279-60-6 |
| Dimethyl (tert-butoxycarbonyl)-D-glutamate | 130622-05-8 |
| tert-butyl (S)-(1,5-dihydroxypentan-2-yl)carbamate | 162955-48-8 |
| tert-butyl (R)-(1,5-dihydroxypentan-2-yl)carbamate | 397246-12-7 |
| (S)-3-Aminopiperidine. Dihydrochloride | 334618-07-4 |
| (R)-3-Aminopiperidine. Dihydrochloride | 334618-23-4 |
| 3-Aminopiperidine. Dihydrochloride (Racemic) | 138060-07-8 |
| tert-butyl pyridin-3-ylcarbamate | 56700-70-0 |
| tert-butyl piperidin-3-ylcarbamate (Racemic) | 172603-05-3 |
| tert-butyl (R)-piperidin-3-yl carbamate | 309956-78-3 |
| tert-butyl (S)-piperidin-3-yl carbamate | 216854-23-8 |
| Lenalidomide | |
| methyl 2-methyl-3-nitrobenzoate | 59382-59-1 |
| methyl 2-(bromomethyl)-3-nitrobenzoate | 98475-07-1 |
| methyl 2-(bromomethyl)-4-nitrobenzoate | 133446-99-8 |
| methyl 2-(bromomethyl)-5-nitrobenzoate | |
| 90725-68-1 | |
| methyl 2-(bromomethyl)-6-nitrobenzoate | 61940-21-4 |
| (tert-butoxycarbonyl)-L-glutamine | 13726-85-7 |
| tert-butyl (2,6-dioxopiperidin-3-yl)carbamate | |
| 31140-42-8 | |
| 3-aminopiperidine-2,6-dione hydrochloride | 24666-56-6 |
| 3-(7-Nitro-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione | 827026-45-9 |
| Lenalidomide - API Standard/3-(4-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione | 191732-72-6 |
| Mirabegron | |
| N-(4-nitrophenethyl)acetamide | 1596293 |
| N-(2-nitrophenethyl)acetamide | 315663-43-5 |
| 2-(4-nitrophenyl)ethan-1-amine hydrochloride/ Imp-E(EP) | 29968-78-3 |
| 2-(2-nitrophenyl)ethan-1-amine hydrochloride | 861337-74-8 |
| ethyl 2-(2-aminothiazol-4-yl)acetate | 53266-94-7 |
| 2-(2-aminothiazol-4-yl)acetic acid hydrochloride | 66659-20-9 |
| 2-(2-aminothiazol-4-yl)acetic acid | 29676-71-9 |
| (R)-1-phenylethane-1,2-diol | 16355-00-3 |
| (S)-1-phenylethane-1,2-diol | 25779-13-9 |
| (R)-2-hydroxy-N-(4-nitrophenethyl)-2-phenylacetamide/Imp-G(EP) | 521284-19-5 |
| (S)-2-hydroxy-N-(4-nitrophenethyl)-2-phenylacetamide | 2193505-55-2 |
| (R)-2-hydroxy-N-(2-nitrophenethyl)-2-phenylacetamide | 1684452-87-6 |
| N-(4-nitrophenethyl)-2-phenylacetamide | 83303-98-4 |
| (R)-2-((4-nitrophenethyl)amino)-1-phenylethan-1-ol hydrochloride/Imp-F (EP) | 521284-21-9 |
| (R)-2-((4-nitrophenethyl)amino)-1-phenylethan-1-ol | 223673-34-5 |
| (S)-2-((4-nitrophenethyl)amino)-1-phenylethan-1-ol hydrochloride | 2184223-32-1 |
| N-(4-nitrophenethyl)-2-phenylethan-1-amine | 1154949-80-0 |
| (R)-2-((2-nitrophenethyl)amino)-1-phenylethan-1-ol | N.A |
| (R)-2-((4-aminophenethyl) amino)-1-phenylethan-1-ol Hydrochloride /Imp-B (EP) | 521284-22-0 |
| (R)-2-((4-aminophenethyl)amino)-1-phenylethan-1-ol | 391901-45-4 |
| (S)-2-((4-aminophenethyl) amino)-1-phenylethan-1-ol hydrochloride | 1624261-01-3 |
| (R)-2-((2-aminophenethyl) amino)-1-phenylethan-1-ol | 2826361-99-1 |
| 4-(2-(phenethylamino)ethyl)aniline hydrochloride | 1581285-26-8 |
| (R)-2-(2-aminothiazol-4-yl)-N-(4-(2-((2-hydroxy-2-phenylethyl) amino)ethyl)phenyl)acetamide/API | 223673-61-8 |
| (S)-2-(2-aminothiazol-4-yl)-N-(4-(2-((2-hydroxy-2-phenylethyl) amino)ethyl)phenyl)acetamide/ Imp-A (EP) | 1796931-48-0 |
| (R)-2-(2-aminothiazol-4-yl)-N-(2-(2-((2-hydroxy-2-phenylethyl) amino)ethyl)phenyl)acetamide | 1684452-80-9 |
| 2-(2-aminothiazol-4-yl)-N-(4-(2-(phenethylamino)ethyl)phenyl)acetamide | 1581284-79-8 |
| Dabigatran Etexilate Mesylate | |
| Ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate/ Imp-B | 211915-84-3 |
| Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate/ Imp-C | 429658-95-7 |
| ethyl 3-(2-(((4-(N-(ethoxycarbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate/Imp-E | 1416446-40-6 |
| ethyl 3-(1-methyl-2-(((4-(N-((pentyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate/ Imp-F | 1416446-45-1 |
| ethyl 3-(2-(((4-(N-((heptyloxy)carbonyl)carbamimidoyl) | 1349500-09-9 |
| phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)- | |
| 1H-benzo[d]imidazole-5-carboxamido)propanoate/ | |
| Imp-G | |
| 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1 | 212321-78-3 |
| -methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid | |
| ethyl 2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl) phenyl)amino) methyl)-1-methyl-1H-benzo[d]imidazole-5-carboxylate | 1408238-36-7 |
| methyl 2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazole-5-carboxylate | N.A |
| Ethyl 3-(2-(chloromethyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | 1307233-94-8 |
| Hexyl ((4-aminophenyl)(imino)methyl) | 1307233-93-7 |
| carbamate hydrochloride | |
| Ethyl 3-[[2-[[4-[[(hexyloxy)carbonyl]carbamoyl]anilino]methyl]-1-methyl-1H-benzimidazole5-carbonyl] (pyridin-2-yl)amino]propanoate | 1408238-40-3 |
| N-[[2-[[[4-[[[(Hexyloxy) carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl] carbonyl]-N-2-pyridinyl-β-alanine; O-Desethyl Dabigatran Etexilate impurity | 212321-78-3 |
| 3-(2-(((4-(((Hexyloxy)carbonyl)carbamoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid | 1408238-37-8 |
| Dabigatran Etexilate Base(SMUI –NMT 0.1%, Purity > 99.5%) | 211915-06-9 |
| Dabigatran Etexilate Mesylate (API) | 872728-21-9 |
| hexyl ((4-(((hexyloxy) carbonyl)amino)phenyl)(imino)methyl)carbamate | N.A |
| Ethyl ((4-aminophenyl)(imino)methyl)carbamate hydrochloride | NA |
| Pentyl ((4-aminophenyl)(imino)methyl)carbamate hydrochloride | NA |
| Heptyl ((4-aminophenyl)(imino)methyl)carbamate hydrochloride | NA |
| Escitalopram | |
| 4-(4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile/Citadiol base | 103146-25-4 |
| (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt | 128173-53-5 |
| (S)-4-(4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | 488787-59-3 |
| (R)-4-(4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | 481047-48-7 |
| Miscellaneous | |
| Cyclen (99%) | 294-90-6 |
| Cyclen. Tetra hydrochloride(99%) | 10045-25-7 |
| DOTA. Tetra hydrochloride(99%) | NA |
| DOTA/ Tetraxetane(USP)(99%) | 60239-18-1 |
| methyl 3-methyl-4-nitrobenzoat | 24078-71-5 |